Volume 30, Number 10—October 2024
Dispatch
Circovirus Hepatitis in Immunocompromised Patient, Switzerland
Figure 1

Figure 1. Clinical course of patient with hepatitis of unknown origin, Switzerland, November 2021–April 2024. Top of timeline shows results of enzyme level testing, expressed as units per liter; bottom of timeline shows clinical course. ALP, alkaline phosphatase; ALT, alanine aminotransferase; ARDS, acute respiratory distress syndrome; AST, aspartate aminotransferase; GGT, gammaglutamyl transferase; HCirV-1, human circovirus; mNGS, metagenomic next-generation sequencing; MRCP, magnetic resonance cholangiopancreatography; PCV3, porcine circovirus 3.
1These first authors contributed equally to this article.
2These senior authors contributed equally to this article.
Page created: August 13, 2024
Page updated: September 23, 2024
Page reviewed: September 23, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.